Literature DB >> 22538085

Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian.

Dezso Nemeth1, Cristina D Dye, Tamás Sefcsik, Karolina Janacsek, Zsolt Turi, Zsuzsa Londe, Péter Klivenyi, Zsigmond Tamás Kincses, Nikoletta Szabó, László Vecsei, Michael T Ullman.   

Abstract

A limited number of studies have investigated language in Huntington's disease (HD). These have generally reported abnormalities in rule-governed (grammatical) aspects of language, in both syntax and morphology. Several studies of verbal inflectional morphology in English and French have reported evidence of over-active rule processing, such as over-suffixation errors (e.g., walkeded) and over-regularizations (e.g., digged). Here we extend the investigation to noun inflection in Hungarian, a Finno-Ugric agglutinative language with complex morphology, and to genetically proven pre-symptomatic Huntington's disease (pre-HD). Although individuals with pre-HD have no clinical, motor or cognitive symptoms, the underlying pathology may already have begun, and thus sensitive behavioral measures might reveal already-present impairments. Indeed, in a Hungarian morphology production task, pre-HD patients made both over-suffixation and over-regularization errors. The findings suggest the generality of over-active rule processing in both HD and pre-HD, across languages from different families with different morphological systems, and for both verbal and noun inflection. Because the neuropathology in pre-HD appears to be largely restricted to the caudate nucleus and related structures, the findings further implicate these structures in language, and in rule-processing in particular. Finally, the need for effective treatments in HD, which will likely depend in part on the ability to sensitively measure early changes in the disease, suggests the possibility that inflectional morphology, and perhaps other language measures, may provide useful diagnostic, tracking, and therapeutic tools for assessing and treating early degeneration in pre-HD and HD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22538085      PMCID: PMC3350800          DOI: 10.1016/j.bandl.2012.04.001

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  31 in total

1.  Productive syntax abilities in Huntington's and Parkinson's diseases.

Authors:  L L Murray; L P Lenz
Journal:  Brain Cogn       Date:  2001 Jun-Jul       Impact factor: 2.310

2.  An ER-fMRI investigation of morphological inflection in German reveals that the brain makes a distinction between regular and irregular forms.

Authors:  Alan Beretta; Carrie Campbell; Thomas H Carr; Jie Huang; Lothar M Schmitt; Kiel Christianson; Yue Cao
Journal:  Brain Lang       Date:  2003-04       Impact factor: 2.381

Review 3.  Specific language impairment is not specific to language: the procedural deficit hypothesis.

Authors:  Michael T Ullman; Elizabeth I Pierpont
Journal:  Cortex       Date:  2005-06       Impact factor: 4.027

4.  Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Authors:  C M Kipps; A J Duggins; N Mahant; L Gomes; J Ashburner; E A McCusker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

5.  The role of the striatum in rule application: the model of Huntington's disease at early stage.

Authors:  Marc Teichmann; Emmanuel Dupoux; Sid Kouider; Pierre Brugières; Marie-Françoise Boissé; Sophie Baudic; Pierre Cesaro; Marc Peschanski; Anne-Catherine Bachoud-Lévi
Journal:  Brain       Date:  2005-03-23       Impact factor: 13.501

6.  Striatal degeneration impairs language learning: evidence from Huntington's disease.

Authors:  R De Diego-Balaguer; M Couette; G Dolbeau; A Dürr; K Youssov; A-C Bachoud-Lévi
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

7.  Complex language functions and subcortical mechanisms: evidence from Huntington's disease and patients with non-thalamic subcortical lesions.

Authors:  Helen J Chenery; David A Copland; Bruce E Murdoch
Journal:  Int J Lang Commun Disord       Date:  2002 Oct-Dec       Impact factor: 3.020

8.  Predictors of diagnosis in Huntington disease.

Authors:  Douglas R Langbehn; Jane S Paulsen
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

9.  Evidence for specific cognitive deficits in preclinical Huntington's disease.

Authors:  A D Lawrence; J R Hodges; A E Rosser; A Kershaw; C ffrench-Constant; D C Rubinsztein; T W Robbins; B J Sahakian
Journal:  Brain       Date:  1998-07       Impact factor: 13.501

10.  Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Authors:  Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; James A Mills; Douglas R Langbehn; Hans J Johnson; Vincent A Magnotta; Ronald K Pierson; Leigh J Beglinger; Martha A Nance; Roger A Barker; Jane S Paulsen
Journal:  Brain       Date:  2010-10-04       Impact factor: 13.501

View more
  3 in total

1.  Predicting clinical scores in Huntington's disease: a lightweight speech test.

Authors:  Rachid Riad; Marine Lunven; Hadrien Titeux; Xuan-Nga Cao; Jennifer Hamet Bagnou; Laurie Lemoine; Justine Montillot; Agnes Sliwinski; Katia Youssov; Laurent Cleret de Langavant; Emmanuel Dupoux; Anne-Catherine Bachoud-Lévi
Journal:  J Neurol       Date:  2022-05-14       Impact factor: 6.682

2.  Understanding speech and swallowing difficulties in individuals with Huntington disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Angela Roberts; Praveen Dayalu; Dana L Hanifan; Jennifer A Miner; Daniel Claassen; Emily Mower Provost
Journal:  Qual Life Res       Date:  2020-08-24       Impact factor: 4.147

3.  The production of nominal and verbal inflection in an agglutinative language: evidence from Hungarian.

Authors:  Dezso Nemeth; Karolina Janacsek; Zsolt Turi; Agnes Lukacs; Don Peckham; Szilvia Szanka; Dorottya Gazso; Noemi Lovassy; Michael T Ullman
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.